Ari Maizel's Insider Trades & SAST Disclosures

Ari Maizel's most recent trade in Axsome Therapeutics Inc was a trade of 7,816 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 21, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Axsome Therapeutics Inc
Ari Maizel Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 7,816 7,816 - - Employee Stock Option (Right to Buy)
Axsome Therapeutics Inc
Ari Maizel Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 7,740 7,740 - - Performance Stock Units
Axsome Therapeutics Inc
Ari Maizel Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Feb 2025 7,740 7,740 - - Restricted Stock Units
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades